1. Home
  2. UAN vs BLFS Comparison

UAN vs BLFS Comparison

Compare UAN & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVR Partners LP

UAN

CVR Partners LP

HOLD

Current Price

$129.22

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

HOLD

Current Price

$18.90

Market Cap

923.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAN
BLFS
Founded
2007
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
923.5M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
UAN
BLFS
Price
$129.22
$18.90
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$32.00
AVG Volume (30 Days)
99.8K
485.3K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
8.03%
N/A
EPS Growth
61.98
77.27
EPS
9.33
N/A
Revenue
$606,038,000.00
$96,214,000.00
Revenue This Year
N/A
$19.73
Revenue Next Year
N/A
$17.82
P/E Ratio
$14.18
N/A
Revenue Growth
15.36
16.97
52 Week Low
$63.45
$17.86
52 Week High
$139.50
$29.57

Technical Indicators

Market Signals
Indicator
UAN
BLFS
Relative Strength Index (RSI) 58.87 37.80
Support Level $89.52 $17.86
Resistance Level $139.50 $25.95
Average True Range (ATR) 7.23 0.89
MACD 0.97 0.00
Stochastic Oscillator 68.95 26.21

Price Performance

Historical Comparison
UAN
BLFS

About UAN CVR Partners LP

CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: